Pharma & Healthcare
Global Immune Globulin Intravenous Market Research Report 2025
- Sep 09, 25
- ID: 497198
- Pages: 96
- Figures: 89
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immune Globulin Intravenous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulin Intravenous.
The Immune Globulin Intravenous market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune Globulin Intravenous market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Globulin Intravenous manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Globulin Intravenous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Globulin Intravenous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Immune Globulin Intravenous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulin Intravenous.
The Immune Globulin Intravenous market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune Globulin Intravenous market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Globulin Intravenous manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Globulin Intravenous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Globulin Intravenous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Immune Globulin Intravenous Market Overview
1.1 Product Definition
1.2 Immune Globulin Intravenous by Type
1.2.1 Global Immune Globulin Intravenous Market Value Comparison by Type (2024 VS 2031)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Immune Globulin Intravenous by Application
1.3.1 Global Immune Globulin Intravenous Market Value by Application (2024 VS 2031)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulin Intravenous Market Size Estimates and Forecasts
1.4.1 Global Immune Globulin Intravenous Revenue 2020-2031
1.4.2 Global Immune Globulin Intravenous Sales 2020-2031
1.4.3 Global Immune Globulin Intravenous Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Immune Globulin Intravenous Market Competition by Manufacturers
2.1 Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2020-2025)
2.2 Global Immune Globulin Intravenous Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Immune Globulin Intravenous Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Immune Globulin Intravenous, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Globulin Intravenous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Globulin Intravenous, Product Type & Application
2.7 Global Key Manufacturers of Immune Globulin Intravenous, Date of Enter into This Industry
2.8 Global Immune Globulin Intravenous Market Competitive Situation and Trends
2.8.1 Global Immune Globulin Intravenous Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Immune Globulin Intravenous Players Market Share by Revenue
2.8.3 Global Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immune Globulin Intravenous Market Scenario by Region
3.1 Global Immune Globulin Intravenous Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Immune Globulin Intravenous Sales by Region: 2020-2031
3.2.1 Global Immune Globulin Intravenous Sales by Region: 2020-2025
3.2.2 Global Immune Globulin Intravenous Sales by Region: 2026-2031
3.3 Global Immune Globulin Intravenous Revenue by Region: 2020-2031
3.3.1 Global Immune Globulin Intravenous Revenue by Region: 2020-2025
3.3.2 Global Immune Globulin Intravenous Revenue by Region: 2026-2031
3.4 North America Immune Globulin Intravenous Market Facts & Figures by Country
3.4.1 North America Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Immune Globulin Intravenous Sales by Country (2020-2031)
3.4.3 North America Immune Globulin Intravenous Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Immune Globulin Intravenous Market Facts & Figures by Country
3.5.1 Europe Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Immune Globulin Intravenous Sales by Country (2020-2031)
3.5.3 Europe Immune Globulin Intravenous Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Globulin Intravenous Market Facts & Figures by Region
3.6.1 Asia Pacific Immune Globulin Intravenous Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Immune Globulin Intravenous Sales by Region (2020-2031)
3.6.3 Asia Pacific Immune Globulin Intravenous Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immune Globulin Intravenous Market Facts & Figures by Country
3.7.1 Latin America Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Immune Globulin Intravenous Sales by Country (2020-2031)
3.7.3 Latin America Immune Globulin Intravenous Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Globulin Intravenous Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Immune Globulin Intravenous Sales by Country (2020-2031)
3.8.3 Middle East and Africa Immune Globulin Intravenous Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Globulin Intravenous Sales by Type (2020-2031)
4.1.1 Global Immune Globulin Intravenous Sales by Type (2020-2025)
4.1.2 Global Immune Globulin Intravenous Sales by Type (2026-2031)
4.1.3 Global Immune Globulin Intravenous Sales Market Share by Type (2020-2031)
4.2 Global Immune Globulin Intravenous Revenue by Type (2020-2031)
4.2.1 Global Immune Globulin Intravenous Revenue by Type (2020-2025)
4.2.2 Global Immune Globulin Intravenous Revenue by Type (2026-2031)
4.2.3 Global Immune Globulin Intravenous Revenue Market Share by Type (2020-2031)
4.3 Global Immune Globulin Intravenous Price by Type (2020-2031)
5 Segment by Application
5.1 Global Immune Globulin Intravenous Sales by Application (2020-2031)
5.1.1 Global Immune Globulin Intravenous Sales by Application (2020-2025)
5.1.2 Global Immune Globulin Intravenous Sales by Application (2026-2031)
5.1.3 Global Immune Globulin Intravenous Sales Market Share by Application (2020-2031)
5.2 Global Immune Globulin Intravenous Revenue by Application (2020-2031)
5.2.1 Global Immune Globulin Intravenous Revenue by Application (2020-2025)
5.2.2 Global Immune Globulin Intravenous Revenue by Application (2026-2031)
5.2.3 Global Immune Globulin Intravenous Revenue Market Share by Application (2020-2031)
5.3 Global Immune Globulin Intravenous Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Immune Globulin Intravenous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Immune Globulin Intravenous Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Immune Globulin Intravenous Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Immune Globulin Intravenous Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Company Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biotest Immune Globulin Intravenous Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kedrion Immune Globulin Intravenous Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.7.1 Hualan Bio Company Information
6.7.2 Hualan Bio Description and Business Overview
6.7.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Bio Immune Globulin Intravenous Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Company Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CNBG Immune Globulin Intravenous Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Company Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai RAAS Immune Globulin Intravenous Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Immune Globulin Intravenous Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Company Information
6.11.2 LFB Group Description and Business Overview
6.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LFB Group Immune Globulin Intravenous Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Company Information
6.12.2 BPL Description and Business Overview
6.12.3 BPL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPL Immune Globulin Intravenous Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Company Information
6.13.2 Sichuan Yuanda Shuyang Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Globulin Intravenous Industry Chain Analysis
7.2 Immune Globulin Intravenous Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Globulin Intravenous Production Mode & Process Analysis
7.4 Immune Globulin Intravenous Sales and Marketing
7.4.1 Immune Globulin Intravenous Sales Channels
7.4.2 Immune Globulin Intravenous Distributors
7.5 Immune Globulin Intravenous Customer Analysis
8 Immune Globulin Intravenous Market Dynamics
8.1 Immune Globulin Intravenous Industry Trends
8.2 Immune Globulin Intravenous Market Drivers
8.3 Immune Globulin Intravenous Market Challenges
8.4 Immune Globulin Intravenous Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Immune Globulin Intravenous by Type
1.2.1 Global Immune Globulin Intravenous Market Value Comparison by Type (2024 VS 2031)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Immune Globulin Intravenous by Application
1.3.1 Global Immune Globulin Intravenous Market Value by Application (2024 VS 2031)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulin Intravenous Market Size Estimates and Forecasts
1.4.1 Global Immune Globulin Intravenous Revenue 2020-2031
1.4.2 Global Immune Globulin Intravenous Sales 2020-2031
1.4.3 Global Immune Globulin Intravenous Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Immune Globulin Intravenous Market Competition by Manufacturers
2.1 Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2020-2025)
2.2 Global Immune Globulin Intravenous Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Immune Globulin Intravenous Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Immune Globulin Intravenous, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Globulin Intravenous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Globulin Intravenous, Product Type & Application
2.7 Global Key Manufacturers of Immune Globulin Intravenous, Date of Enter into This Industry
2.8 Global Immune Globulin Intravenous Market Competitive Situation and Trends
2.8.1 Global Immune Globulin Intravenous Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Immune Globulin Intravenous Players Market Share by Revenue
2.8.3 Global Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immune Globulin Intravenous Market Scenario by Region
3.1 Global Immune Globulin Intravenous Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Immune Globulin Intravenous Sales by Region: 2020-2031
3.2.1 Global Immune Globulin Intravenous Sales by Region: 2020-2025
3.2.2 Global Immune Globulin Intravenous Sales by Region: 2026-2031
3.3 Global Immune Globulin Intravenous Revenue by Region: 2020-2031
3.3.1 Global Immune Globulin Intravenous Revenue by Region: 2020-2025
3.3.2 Global Immune Globulin Intravenous Revenue by Region: 2026-2031
3.4 North America Immune Globulin Intravenous Market Facts & Figures by Country
3.4.1 North America Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Immune Globulin Intravenous Sales by Country (2020-2031)
3.4.3 North America Immune Globulin Intravenous Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Immune Globulin Intravenous Market Facts & Figures by Country
3.5.1 Europe Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Immune Globulin Intravenous Sales by Country (2020-2031)
3.5.3 Europe Immune Globulin Intravenous Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Globulin Intravenous Market Facts & Figures by Region
3.6.1 Asia Pacific Immune Globulin Intravenous Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Immune Globulin Intravenous Sales by Region (2020-2031)
3.6.3 Asia Pacific Immune Globulin Intravenous Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immune Globulin Intravenous Market Facts & Figures by Country
3.7.1 Latin America Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Immune Globulin Intravenous Sales by Country (2020-2031)
3.7.3 Latin America Immune Globulin Intravenous Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Globulin Intravenous Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Globulin Intravenous Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Immune Globulin Intravenous Sales by Country (2020-2031)
3.8.3 Middle East and Africa Immune Globulin Intravenous Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Globulin Intravenous Sales by Type (2020-2031)
4.1.1 Global Immune Globulin Intravenous Sales by Type (2020-2025)
4.1.2 Global Immune Globulin Intravenous Sales by Type (2026-2031)
4.1.3 Global Immune Globulin Intravenous Sales Market Share by Type (2020-2031)
4.2 Global Immune Globulin Intravenous Revenue by Type (2020-2031)
4.2.1 Global Immune Globulin Intravenous Revenue by Type (2020-2025)
4.2.2 Global Immune Globulin Intravenous Revenue by Type (2026-2031)
4.2.3 Global Immune Globulin Intravenous Revenue Market Share by Type (2020-2031)
4.3 Global Immune Globulin Intravenous Price by Type (2020-2031)
5 Segment by Application
5.1 Global Immune Globulin Intravenous Sales by Application (2020-2031)
5.1.1 Global Immune Globulin Intravenous Sales by Application (2020-2025)
5.1.2 Global Immune Globulin Intravenous Sales by Application (2026-2031)
5.1.3 Global Immune Globulin Intravenous Sales Market Share by Application (2020-2031)
5.2 Global Immune Globulin Intravenous Revenue by Application (2020-2031)
5.2.1 Global Immune Globulin Intravenous Revenue by Application (2020-2025)
5.2.2 Global Immune Globulin Intravenous Revenue by Application (2026-2031)
5.2.3 Global Immune Globulin Intravenous Revenue Market Share by Application (2020-2031)
5.3 Global Immune Globulin Intravenous Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Immune Globulin Intravenous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Immune Globulin Intravenous Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Immune Globulin Intravenous Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Immune Globulin Intravenous Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Company Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biotest Immune Globulin Intravenous Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kedrion Immune Globulin Intravenous Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.7.1 Hualan Bio Company Information
6.7.2 Hualan Bio Description and Business Overview
6.7.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Bio Immune Globulin Intravenous Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Company Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CNBG Immune Globulin Intravenous Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Company Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai RAAS Immune Globulin Intravenous Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Immune Globulin Intravenous Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Company Information
6.11.2 LFB Group Description and Business Overview
6.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LFB Group Immune Globulin Intravenous Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Company Information
6.12.2 BPL Description and Business Overview
6.12.3 BPL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPL Immune Globulin Intravenous Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Company Information
6.13.2 Sichuan Yuanda Shuyang Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Globulin Intravenous Industry Chain Analysis
7.2 Immune Globulin Intravenous Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Globulin Intravenous Production Mode & Process Analysis
7.4 Immune Globulin Intravenous Sales and Marketing
7.4.1 Immune Globulin Intravenous Sales Channels
7.4.2 Immune Globulin Intravenous Distributors
7.5 Immune Globulin Intravenous Customer Analysis
8 Immune Globulin Intravenous Market Dynamics
8.1 Immune Globulin Intravenous Industry Trends
8.2 Immune Globulin Intravenous Market Drivers
8.3 Immune Globulin Intravenous Market Challenges
8.4 Immune Globulin Intravenous Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Immune Globulin Intravenous Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Immune Globulin Intravenous Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Immune Globulin Intravenous Market Competitive Situation by Manufacturers in 2024
Table 4. Global Immune Globulin Intravenous Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Immune Globulin Intravenous Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Immune Globulin Intravenous Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Immune Globulin Intravenous Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Immune Globulin Intravenous, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Immune Globulin Intravenous, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Immune Globulin Intravenous, Product Type & Application
Table 12. Global Key Manufacturers of Immune Globulin Intravenous, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immune Globulin Intravenous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulin Intravenous as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immune Globulin Intravenous Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Immune Globulin Intravenous Sales by Region (2020-2025) & (K Units)
Table 18. Global Immune Globulin Intravenous Sales Market Share by Region (2020-2025)
Table 19. Global Immune Globulin Intravenous Sales by Region (2026-2031) & (K Units)
Table 20. Global Immune Globulin Intravenous Sales Market Share by Region (2026-2031)
Table 21. Global Immune Globulin Intravenous Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Immune Globulin Intravenous Revenue Market Share by Region (2020-2025)
Table 23. Global Immune Globulin Intravenous Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Immune Globulin Intravenous Revenue Market Share by Region (2026-2031)
Table 25. North America Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 27. North America Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 28. North America Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 32. Europe Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 33. Europe Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Immune Globulin Intravenous Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Immune Globulin Intravenous Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Immune Globulin Intravenous Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Immune Globulin Intravenous Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Immune Globulin Intravenous Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Immune Globulin Intravenous Sales (K Units) by Type (2020-2025)
Table 51. Global Immune Globulin Intravenous Sales (K Units) by Type (2026-2031)
Table 52. Global Immune Globulin Intravenous Sales Market Share by Type (2020-2025)
Table 53. Global Immune Globulin Intravenous Sales Market Share by Type (2026-2031)
Table 54. Global Immune Globulin Intravenous Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Immune Globulin Intravenous Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Immune Globulin Intravenous Revenue Market Share by Type (2020-2025)
Table 57. Global Immune Globulin Intravenous Revenue Market Share by Type (2026-2031)
Table 58. Global Immune Globulin Intravenous Price (USD/Unit) by Type (2020-2025)
Table 59. Global Immune Globulin Intravenous Price (USD/Unit) by Type (2026-2031)
Table 60. Global Immune Globulin Intravenous Sales (K Units) by Application (2020-2025)
Table 61. Global Immune Globulin Intravenous Sales (K Units) by Application (2026-2031)
Table 62. Global Immune Globulin Intravenous Sales Market Share by Application (2020-2025)
Table 63. Global Immune Globulin Intravenous Sales Market Share by Application (2026-2031)
Table 64. Global Immune Globulin Intravenous Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Immune Globulin Intravenous Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Immune Globulin Intravenous Revenue Market Share by Application (2020-2025)
Table 67. Global Immune Globulin Intravenous Revenue Market Share by Application (2026-2031)
Table 68. Global Immune Globulin Intravenous Price (USD/Unit) by Application (2020-2025)
Table 69. Global Immune Globulin Intravenous Price (USD/Unit) by Application (2026-2031)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Immune Globulin Intravenous Product
Table 74. Takeda Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Immune Globulin Intravenous Product
Table 79. Grifols Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. CSL Immune Globulin Intravenous Product
Table 84. CSL Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Octapharma Immune Globulin Intravenous Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Biotest Company Information
Table 91. Biotest Description and Business Overview
Table 92. Biotest Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biotest Immune Globulin Intravenous Product
Table 94. Biotest Recent Developments/Updates
Table 95. Kedrion Company Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Kedrion Immune Globulin Intravenous Product
Table 99. Kedrion Recent Developments/Updates
Table 100. Hualan Bio Company Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Hualan Bio Immune Globulin Intravenous Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. CNBG Company Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. CNBG Immune Globulin Intravenous Product
Table 109. CNBG Recent Developments/Updates
Table 110. Shanghai RAAS Company Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Shanghai RAAS Immune Globulin Intravenous Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. CBPO Company Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. CBPO Immune Globulin Intravenous Product
Table 119. CBPO Recent Developments/Updates
Table 120. LFB Group Company Information
Table 121. LFB Group Description and Business Overview
Table 122. LFB Group Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. LFB Group Immune Globulin Intravenous Product
Table 124. LFB Group Recent Developments/Updates
Table 125. BPL Company Information
Table 126. BPL Description and Business Overview
Table 127. BPL Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. BPL Immune Globulin Intravenous Product
Table 129. BPL Recent Developments/Updates
Table 130. Sichuan Yuanda Shuyang Company Information
Table 131. Sichuan Yuanda Shuyang Description and Business Overview
Table 132. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product
Table 134. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Immune Globulin Intravenous Distributors List
Table 138. Immune Globulin Intravenous Customers List
Table 139. Immune Globulin Intravenous Market Trends
Table 140. Immune Globulin Intravenous Market Drivers
Table 141. Immune Globulin Intravenous Market Challenges
Table 142. Immune Globulin Intravenous Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Immune Globulin Intravenous
Figure 2. Global Immune Globulin Intravenous Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immune Globulin Intravenous Market Share by Type: 2024 & 2031
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Immune Globulin Intravenous Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Immune Globulin Intravenous Market Share by Application: 2024 & 2031
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Immune Globulin Intravenous Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Immune Globulin Intravenous Market Size (2020-2031) & (US$ Million)
Figure 13. Global Immune Globulin Intravenous Sales (2020-2031) & (K Units)
Figure 14. Global Immune Globulin Intravenous Average Price (USD/Unit) & (2020-2031)
Figure 15. Immune Globulin Intravenous Report Years Considered
Figure 16. Immune Globulin Intravenous Sales Share by Manufacturers in 2024
Figure 17. Global Immune Globulin Intravenous Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Immune Globulin Intravenous Players: Market Share by Revenue in Immune Globulin Intravenous in 2024
Figure 19. Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Immune Globulin Intravenous Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 22. North America Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 23. the United States Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 26. Europe Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 27. Germany Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Immune Globulin Intravenous Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Immune Globulin Intravenous Revenue Market Share by Region (2020-2031)
Figure 34. China Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 44. Latin America Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Immune Globulin Intravenous by Type (2020-2031)
Figure 54. Global Revenue Market Share of Immune Globulin Intravenous by Type (2020-2031)
Figure 55. Global Immune Globulin Intravenous Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Immune Globulin Intravenous by Application (2020-2031)
Figure 57. Global Revenue Market Share of Immune Globulin Intravenous by Application (2020-2031)
Figure 58. Global Immune Globulin Intravenous Price (USD/Unit) by Application (2020-2031)
Figure 59. Immune Globulin Intravenous Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Immune Globulin Intravenous Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Immune Globulin Intravenous Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Immune Globulin Intravenous Market Competitive Situation by Manufacturers in 2024
Table 4. Global Immune Globulin Intravenous Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Immune Globulin Intravenous Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Immune Globulin Intravenous Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Immune Globulin Intravenous Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Immune Globulin Intravenous, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Immune Globulin Intravenous, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Immune Globulin Intravenous, Product Type & Application
Table 12. Global Key Manufacturers of Immune Globulin Intravenous, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immune Globulin Intravenous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulin Intravenous as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immune Globulin Intravenous Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Immune Globulin Intravenous Sales by Region (2020-2025) & (K Units)
Table 18. Global Immune Globulin Intravenous Sales Market Share by Region (2020-2025)
Table 19. Global Immune Globulin Intravenous Sales by Region (2026-2031) & (K Units)
Table 20. Global Immune Globulin Intravenous Sales Market Share by Region (2026-2031)
Table 21. Global Immune Globulin Intravenous Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Immune Globulin Intravenous Revenue Market Share by Region (2020-2025)
Table 23. Global Immune Globulin Intravenous Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Immune Globulin Intravenous Revenue Market Share by Region (2026-2031)
Table 25. North America Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 27. North America Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 28. North America Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 32. Europe Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 33. Europe Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Immune Globulin Intravenous Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Immune Globulin Intravenous Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Immune Globulin Intravenous Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Immune Globulin Intravenous Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Immune Globulin Intravenous Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Immune Globulin Intravenous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Immune Globulin Intravenous Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Immune Globulin Intravenous Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Immune Globulin Intravenous Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Immune Globulin Intravenous Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Immune Globulin Intravenous Sales (K Units) by Type (2020-2025)
Table 51. Global Immune Globulin Intravenous Sales (K Units) by Type (2026-2031)
Table 52. Global Immune Globulin Intravenous Sales Market Share by Type (2020-2025)
Table 53. Global Immune Globulin Intravenous Sales Market Share by Type (2026-2031)
Table 54. Global Immune Globulin Intravenous Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Immune Globulin Intravenous Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Immune Globulin Intravenous Revenue Market Share by Type (2020-2025)
Table 57. Global Immune Globulin Intravenous Revenue Market Share by Type (2026-2031)
Table 58. Global Immune Globulin Intravenous Price (USD/Unit) by Type (2020-2025)
Table 59. Global Immune Globulin Intravenous Price (USD/Unit) by Type (2026-2031)
Table 60. Global Immune Globulin Intravenous Sales (K Units) by Application (2020-2025)
Table 61. Global Immune Globulin Intravenous Sales (K Units) by Application (2026-2031)
Table 62. Global Immune Globulin Intravenous Sales Market Share by Application (2020-2025)
Table 63. Global Immune Globulin Intravenous Sales Market Share by Application (2026-2031)
Table 64. Global Immune Globulin Intravenous Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Immune Globulin Intravenous Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Immune Globulin Intravenous Revenue Market Share by Application (2020-2025)
Table 67. Global Immune Globulin Intravenous Revenue Market Share by Application (2026-2031)
Table 68. Global Immune Globulin Intravenous Price (USD/Unit) by Application (2020-2025)
Table 69. Global Immune Globulin Intravenous Price (USD/Unit) by Application (2026-2031)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Immune Globulin Intravenous Product
Table 74. Takeda Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Immune Globulin Intravenous Product
Table 79. Grifols Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. CSL Immune Globulin Intravenous Product
Table 84. CSL Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Octapharma Immune Globulin Intravenous Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Biotest Company Information
Table 91. Biotest Description and Business Overview
Table 92. Biotest Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biotest Immune Globulin Intravenous Product
Table 94. Biotest Recent Developments/Updates
Table 95. Kedrion Company Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Kedrion Immune Globulin Intravenous Product
Table 99. Kedrion Recent Developments/Updates
Table 100. Hualan Bio Company Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Hualan Bio Immune Globulin Intravenous Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. CNBG Company Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. CNBG Immune Globulin Intravenous Product
Table 109. CNBG Recent Developments/Updates
Table 110. Shanghai RAAS Company Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Shanghai RAAS Immune Globulin Intravenous Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. CBPO Company Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. CBPO Immune Globulin Intravenous Product
Table 119. CBPO Recent Developments/Updates
Table 120. LFB Group Company Information
Table 121. LFB Group Description and Business Overview
Table 122. LFB Group Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. LFB Group Immune Globulin Intravenous Product
Table 124. LFB Group Recent Developments/Updates
Table 125. BPL Company Information
Table 126. BPL Description and Business Overview
Table 127. BPL Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. BPL Immune Globulin Intravenous Product
Table 129. BPL Recent Developments/Updates
Table 130. Sichuan Yuanda Shuyang Company Information
Table 131. Sichuan Yuanda Shuyang Description and Business Overview
Table 132. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product
Table 134. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Immune Globulin Intravenous Distributors List
Table 138. Immune Globulin Intravenous Customers List
Table 139. Immune Globulin Intravenous Market Trends
Table 140. Immune Globulin Intravenous Market Drivers
Table 141. Immune Globulin Intravenous Market Challenges
Table 142. Immune Globulin Intravenous Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Immune Globulin Intravenous
Figure 2. Global Immune Globulin Intravenous Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immune Globulin Intravenous Market Share by Type: 2024 & 2031
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Immune Globulin Intravenous Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Immune Globulin Intravenous Market Share by Application: 2024 & 2031
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Immune Globulin Intravenous Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Immune Globulin Intravenous Market Size (2020-2031) & (US$ Million)
Figure 13. Global Immune Globulin Intravenous Sales (2020-2031) & (K Units)
Figure 14. Global Immune Globulin Intravenous Average Price (USD/Unit) & (2020-2031)
Figure 15. Immune Globulin Intravenous Report Years Considered
Figure 16. Immune Globulin Intravenous Sales Share by Manufacturers in 2024
Figure 17. Global Immune Globulin Intravenous Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Immune Globulin Intravenous Players: Market Share by Revenue in Immune Globulin Intravenous in 2024
Figure 19. Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Immune Globulin Intravenous Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 22. North America Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 23. the United States Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 26. Europe Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 27. Germany Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Immune Globulin Intravenous Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Immune Globulin Intravenous Revenue Market Share by Region (2020-2031)
Figure 34. China Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 44. Latin America Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Immune Globulin Intravenous Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Immune Globulin Intravenous Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Immune Globulin Intravenous Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Immune Globulin Intravenous by Type (2020-2031)
Figure 54. Global Revenue Market Share of Immune Globulin Intravenous by Type (2020-2031)
Figure 55. Global Immune Globulin Intravenous Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Immune Globulin Intravenous by Application (2020-2031)
Figure 57. Global Revenue Market Share of Immune Globulin Intravenous by Application (2020-2031)
Figure 58. Global Immune Globulin Intravenous Price (USD/Unit) by Application (2020-2031)
Figure 59. Immune Globulin Intravenous Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232